Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression-Reference-Cited by-同舟云学术

Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression

Published:2001-03 Issue:3 Volume:31 Page:208-214
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Corbetta S.,Ballaré E.,Mantovani G.,Lania A.,Losa M.,Di Blasio A. M.,Spada A.

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2362.2001.00786.x/fullpdf

Reference25 articles.

1. Molecular biology of somatostatin receptors;Reisine;Endocrine Rev,1995

2. Cloning and expression of a novel mouse somatostatin receptor (SSTR2B);Vanetti;FEBS Lett,1992

3. Heterogenous expression of two somatostatin receptor subtypes in pituitary tumours;Greenman;J Clin Endocrinol Metab,1994

4. Expression of three somatostatin receptor subtypes in pituitary adenomas. Evidence for preferential SSTR 5 expression in the mammosomatotroph lineage;Greenman;J Clin Endocrinol Metab,1994

5. Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes;Jaquet;J Clin Endocrinol Metab,2000

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenesis of Pituitary Adenomas;Pituitary Adenomas;2022

2. Differences in somatostatin receptor subtype expression in patients with acromegaly: new directions for targeted therapy?;Hormones;2021-10-21

3. gsp Mutation Is Not a Molecular Biomarker of Long-Term Response to First-Generation Somatostatin Receptor Ligands in Acromegaly;Cancers;2021-09-28

4. Drug resistance in pituitary tumours: from cell membrane to intracellular signalling;Nature Reviews Endocrinology;2021-06-30

5. Pituitary Tumors: Genetic and Molecular Factors Underlying Pathogenesis and Clinical Behavior;Neuroendocrinology;2021-02-01